Myocardial fibrosis is a predictor of atrial fibrillation in dilated cardiomyopathy- role of cardiovascular magnetic resonance

4 May 2019 (10:50 - 11:50)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Joana Rigueira

Santa Maria University Hospital (CHULN), CAML, CCUL, Lisbon School of Medicine of the Universidade d, Lisbon (Portugal)

8 More presentations in this session

Presentation thumbnail

Genotypic groups as risk factor for cardiac MR abnormalities and complications in thalassemia major

Doctor A. Pepe (Pisa, IT)

Abstract Slides

Presentation thumbnail

Cardiac magnetic resonance detects early cardiac involvement in HIV patients: oedema and inflammation, which may be reversible with therapy

Doctor A. Seraphim (Nicosia, CY)

Abstract Slides

Presentation thumbnail

Cardiac involvement of Wilsons disease. A myocardial strain and imaging study.

Presentation thumbnail

Left ventricular dysfunction, not myocardial injury, drives use of cardioprotective medications in acute myocarditis: insights from machine learning

Assistant Professor A. Cardona (Todi, IT)

Presentation thumbnail

Relationship between ventricular mechanics and fibro-fatty replacement on cardiac magnetic resonance in arrhythmogenic cardiomyopathy.

Associate Professor M. Perazzolo Marra (Padova, IT)

Abstract Slides

Access the full session

Session thumbnail

Moderated ePosters session 5: tissue characterisation in non-ischaemic heart disease

The Event

EuroCMR 2019

4 May 2019 10:50 CET

You may be interested in

Congress Session

Advanced imaging in heart failure

Congress Session

Ventricular arrhythmias and prevention of sudden cardiac death (1)

Webinar

The role of cardiac magnetic resonance for patients with ventricular arrhythmias and the prevention of sudden cardiac death in light of the 2022 ESC Guidelines

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources